{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T18:31:39Z","timestamp":1774031499221,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.vaccine.2007.03.012","type":"journal-article","created":{"date-parts":[[2007,3,27]],"date-time":"2007-03-27T11:17:26Z","timestamp":1174994246000},"page":"4203-4212","source":"Crossref","is-referenced-by-count":81,"title":["Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-na\u00efve adults at the Walter Reed Army Institute of Research"],"prefix":"10.1016","volume":"25","author":[{"given":"Mark E.","family":"Polhemus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan J.","family":"Magill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James F.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent E.","family":"Kester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris F.","family":"Ockenhouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Lanar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheetij","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnoldo","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine","family":"Soisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carter L.","family":"Diggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally A.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. Ann","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Ware","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Brando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urszula","family":"Krzych","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Claude","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Opokua","family":"Ofori-Anyinam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Els","family":"De-Kock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Ripley","family":"Ballou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"D. Gray","family":"Heppner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.03.012_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.2001.64.1","article-title":"The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden","volume":"64","author":"Breman","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2007.03.012_bib2","unstructured":"Malaria Vaccine Initiative, <http:\/\/www.malariavaccine.org\/> [accessed 21 February 2007]."},{"key":"10.1016\/j.vaccine.2007.03.012_bib3","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1074\/jbc.M311331200","article-title":"A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites","volume":"279","author":"Silvie","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2007.03.012_bib4","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.4049\/jimmunol.155.8.4072","article-title":"T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens","volume":"155","author":"Krzych","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.03.012_bib5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00436-003-1061-9","article-title":"Transcription status of vaccine candidate genes of Plasmodium falciparum during the hepatic phase of its life cycle","volume":"92","author":"Bodescot","year":"2004","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2007.03.012_bib6","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1128\/MCB.9.7.3151","article-title":"Integral membrane protein located in the apical complex of Plasmodium falciparum","volume":"9","author":"Peterson","year":"1989","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.vaccine.2007.03.012_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4269\/ajtmh.2001.65.100","article-title":"Longitudinal study of natural immune response to the Plasmodium falciparum apical membrane antigen (AMA-1) in a holendemic region in Western Kenya: Asembo Bay Cohort Project VIII","volume":"65","author":"Udhayakumar","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2007.03.012_bib8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4269\/ajtmh.1994.51.730","article-title":"High prevalence of natural antibodies against Plasmodium falciparum 83-kilodalton apical membrane antigen (PF83\/AMA-1) as detected by capture-enzyme-linked immunosorbent assay using full-length baculovirus recombinant PF83\/AMA-1","volume":"51","author":"Thomas","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2007.03.012_bib9","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1128\/IAI.64.3.1054-1059.1996","article-title":"Identification of T-cell determinants in natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in an adult population exposed to malaria","volume":"64","author":"Lal","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.012_bib10","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.vaccine.2004.05.031","article-title":"Human antibodies to recombinant protein constructs of Plasmodium falciparum apical membrane antigen 1 (AMA1) and their associations with protection from malaria","volume":"23","author":"Polley","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.03.012_bib11","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1016\/j.vaccine.2005.06.030","article-title":"High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya","volume":"24","author":"Polley","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.03.012_bib12","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0300-9084(03)00002-6","article-title":"Protection against experimental P. falciparum malaria is associated with short AMA-1 peptide analogue alpha-helical structures","volume":"84","author":"Cubillos","year":"2002","journal-title":"Biochimie"},{"key":"10.1016\/j.vaccine.2007.03.012_bib13","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.1128\/IAI.70.12.6961-6967.2002","article-title":"Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood stage malaria","volume":"70","author":"Stowers","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.012_bib14","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/j.vaccine.2004.09.040","article-title":"A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant","volume":"23","author":"Saul","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.03.012_bib15","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1128\/IAI.70.10.5901.2002","article-title":"High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion","volume":"70","author":"Kocken","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.012_bib16","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1128\/IAI.71.8.4749-4758.2003","article-title":"Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1","volume":"71","author":"Mueller","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.012_bib17","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.4049\/jimmunol.172.10.6167","article-title":"Fusion of two malaria vaccine candidate antigens enhances product yield, immunogenicity, and antibody-mediated inhibition of parasite growth in vitro","volume":"172","author":"Pan","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.03.012_bib18","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.vaccine.2005.12.034","article-title":"Enhancement of functional antibody responses to AMA1-C1\/Alhydrogel, a Plasmodium falciparum malaria vaccine, with CpG oligodeoxynucleotide","volume":"24","author":"Mullen","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.03.012_bib20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1517\/14728214.10.3.489","article-title":"Malaria vaccines in development","volume":"10","author":"Ballou","year":"2005","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.vaccine.2007.03.012_bib21","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1128\/IAI.73.6.3677-3685.2005","article-title":"Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria","volume":"73","author":"Malkin","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.012_bib22","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1128\/IAI.70.6.3101-3110.2002","article-title":"Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli","volume":"70","author":"Dutta","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.012_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1586\/14760584.2.2.231","article-title":"Development of RTS, S\/AS02: a purified subunit-based malaria vaccine candidate formulated with a novel adjuvant","volume":"2","author":"Gar\u00e7on","year":"2003","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2007.03.012_bib24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM199701093360202","article-title":"A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria","volume":"336","author":"Stoute","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2007.03.012_bib25","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/318534","article-title":"Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria","volume":"183","author":"Kester","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.03.012_bib26","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(01)06957-4","article-title":"Efficacy of RTS, S\/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial","volume":"358","author":"Bojang","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.03.012_bib27","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(04)17223-1","article-title":"Efficacy of the RTS, S\/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial","volume":"364","author":"Alonso","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.03.012_bib28","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(05)67669-6","article-title":"Duration of protection with RTS, S\/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial","volume":"366","author":"Alonso","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.03.012_bib29","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1128\/IAI.73.4.2116-2122.2005","article-title":"Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum","volume":"73","author":"Dutta","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.012_bib30","doi-asserted-by":"crossref","first-page":"12295","DOI":"10.1073\/pnas.2032858100","article-title":"Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites","volume":"100","author":"Dutta","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.03.012_bib31","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.vaccine.2005.01.142","article-title":"Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research","volume":"23","author":"Heppner","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.03.012_bib32","first-page":"535","article-title":"Erythrocytic growth or invasion inhibition assays with emphasis on suspension culture GIA","volume":"72","author":"Haynes","year":"2002","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.vaccine.2007.03.012_bib33","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1128\/IAI.70.12.6948-6960.2002","article-title":"In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response","volume":"70","author":"Kennedy","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.012_bib34","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4049\/jimmunol.165.1.389","article-title":"CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization","volume":"165","author":"Xu","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.03.012_bib35","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1128\/IAI.73.1.422-430.2005","article-title":"Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1","volume":"73","author":"Cortes","year":"2005","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2007.03.012_bib36","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1371\/journal.pmed.0040093","article-title":"Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali","volume":"4","author":"Takala","year":"2007","journal-title":"PLoS Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07002976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07002976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T05:30:02Z","timestamp":1683783002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07002976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":35,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0264410X07002976"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.03.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}